Research graph
References from Survival and failure types after radiation therapy of vulvar cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
Clinical management of primary vulvar cancer
10.1016/j.ejca.2011.06.007 · 2011 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix
10.1002/14651858.cd002225.pub2 · 2005 · External reference
Chemoradiotherapy for anal squamous cell carcinoma
2016 · External reference
Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF Study
10.1002/1097-0142(20000701)89:1<116::aid-cncr16>3.0.co;2-4 · 2000 · External reference
A proportional hazards model for the subdistribution of a competing risk
10.1080/01621459.1999.10474144 · 1999 · External reference
Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva
10.1016/j.ygyno.2010.09.004 · 2011 · External reference
Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva
10.1002/1097-0142(19950501)75:9<2289::aid-cncr2820750917>3.0.co;2-4 · 1995 · External reference
Adjuvant radiation for vulvar carcinoma: improved local control
10.1016/s0360-3016(97)82500-x · 1997 · External reference
Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group
10.1016/s0360-3016(98)00193-x · 1998 · External reference
Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study
10.1016/s0360-3016(00)00762-8 · 2000 · External reference
A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study
10.1016/j.ygyno.2011.11.003 · 2012 · External reference
Competing risk analyses: How are they different and why should you care?
10.1158/1078-0432.ccr-12-0455 · 2012 · External reference
Risk factors for invasive squamous cell carcinoma of the vulva and vagina–population-based case-control study in Denmark
10.1002/ijc.23446 · 2008 · External reference
Two distinct pathways to development of squamous cell carcinoma of the vulva
10.1155/2011/951250 · 2011 · External reference
Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways
10.1097/01.pgp.0000177646.38266.6a · 2006 · External reference
Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?
10.1016/j.ygyno.2011.05.016 · 2011 · External reference
Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma
10.1016/j.ygyno.2003.11.052 · 2004 · External reference
P16INK4a expression in invasive vulvar squamous cell carcinoma
10.1097/01.pai.0000213118.81343.32 · 2007 · External reference
Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node
10.1016/j.ygyno.2009.12.031 · 2010 · External reference
Locally advanced vulvar cancer in elderly women: is chemoradiation beneficial?
10.1097/coc.0b013e3182467e9f · 2013 · External reference
Theragnostic imaging for radiation oncology: dose-painting by numbers
10.1016/s1470-2045(05)01737-7 · 2005 · External reference
Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality
10.1016/s0360-3016(00)00467-3 · 2000 · External reference
